Eczacıbaşı-Monrol Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
300
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
2
Eczacıbaşı-Monrol General Information
Description
Manufacturer of radioisotopes and radiopharmaceuticals intended to provide hope for a better life for cancer patients. The company offers theragnostic, PET products, cold kits and spect products for diagnosis and treatment in nuclear medicine.
Contact Information
Website
www.monrol.comCorporate Office
- Rüzgarlıbahçe Mahallesi Çam Pınarı Sokak
- Number:3 D:10,11 Beykoz
- 34746 Istanbul
- Turkey
Corporate Office
- Rüzgarlıbahçe Mahallesi Çam Pınarı Sokak
- Number:3 D:10,11 Beykoz
- 34746 Istanbul
- Turkey
Eczacıbaşı-Monrol Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eczacıbaşı-Monrol Comparisons
Industry
Financing
Details
Eczacıbaşı-Monrol Competitors (2)
One of Eczacıbaşı-Monrol’s 2 competitors is isoSolutions, a Corporation company based in Vancouver, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| isoSolutions | Corporation | Vancouver, Canada | ||||
| Medi-Radiopharma Co. | Corporation | Erd, Hungary |
Eczacıbaşı-Monrol Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Eczacıbaşı-Monrol Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Eczacıbaşı-Monrol Acquisitions (2)
Eczacıbaşı-Monrol’s most recent deal was a Merger/Acquisition with Capintec. The deal was made on 30-Nov-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Capintec | 30-Nov-2012 | Merger/Acquisition | Monitoring Equipment | ||
| Molekuler Goruntuleme Ticaret Ve Sanayi | 03-Aug-2011 | Merger/Acquisition | Other Commercial Services |
Eczacıbaşı-Monrol Exits (1)
Eczacıbaşı-Monrol’s most recent exit was on 30-Nov-2012 from Capintec. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Capintec | 30-Nov-2012 | Completed |
|
Eczacıbaşı-Monrol FAQs
-
When was Eczacıbaşı-Monrol founded?
Eczacıbaşı-Monrol was founded in 1995.
-
Where is Eczacıbaşı-Monrol headquartered?
Eczacıbaşı-Monrol is headquartered in Istanbul, Turkey.
-
What is the size of Eczacıbaşı-Monrol?
Eczacıbaşı-Monrol has 300 total employees.
-
What industry is Eczacıbaşı-Monrol in?
Eczacıbaşı-Monrol’s primary industry is Pharmaceuticals.
-
Is Eczacıbaşı-Monrol a private or public company?
Eczacıbaşı-Monrol is a Private company.
-
What is Eczacıbaşı-Monrol’s current revenue?
The current revenue for Eczacıbaşı-Monrol is .
-
Who are Eczacıbaşı-Monrol’s investors?
Bozlu Holding and Eczacıbaşı Holding have invested in Eczacıbaşı-Monrol.
-
Who are Eczacıbaşı-Monrol’s competitors?
isoSolutions and Medi-Radiopharma Co. are competitors of Eczacıbaşı-Monrol.
-
When was Eczacıbaşı-Monrol acquired?
Eczacıbaşı-Monrol was acquired on 05-Apr-2024.
-
Who acquired Eczacıbaşı-Monrol?
Eczacıbaşı-Monrol was acquired by Curium Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
